Landmark Breast Cancer Study Explained by Dr Julia Wilson of Breakthrough Breast Cancer

Hello, I'm Julia Wilson, I'm Head of Research Information at Breakthrough Breast Cancer, and I want to talk to you today about a really exciting study that's just come out in one of the most prestigious medical journals. Scientists have amassed information for the last decade or so, and analysed over 2000 different breast cancers. And what they've found is that breast cancers can be grouped into at least ten different types of breast cancer, and each one will need a specific treatment, and a specific diagnosis. Why this is so exciting is that it will really pave the way towards personalised medicine, and so women will be treated according to the genetic fault of their breast cancer and treatments will be specific to the individual. It's really exciting from a research perspective as well because the Breakthrough Breast Cancer unit at King's College London provided some of the tissue samples and clinical data for this study, and they also helped analyse all of this information, helping doctors in the future decide what is the best treatment for each patient. It's also really exciting because they identified new genes associated with different types of breast cancer, and from this information other scientists can use this and develop new drugs, new special targeted treatments that will have fewer side effects for women with breast cancer. So Breakthrough are really proud to have been involved in a small way in such a landmark study that will really change the face of breast cancer in the future. Thank you.